In colon cancer, infiltrating CD4+ lymphocytes displayed high levels of DNA methylation at the IFN-γ promoter, and consequently required treatment with 5-AZA to enable tumor antigen-stimulated IFN-γ production (Janson et al., 2008; Figure 1). The gene discussed is IFNG; the disease is colonic neoplasm.